Clinical Trials Browser

Phase 2 × Enrolling by invitation × NETWORK × Clear all

NCT06773936 2026-05-06

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Phase 2 Enrolling by invitation

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07062354 2026-05-06

CAPT-HN

Phase 2 Enrolling by invitation

Head and Neck Neoplasms